Comparison of the effects of continuous versus bolus intermittent Furosemide infusion on the pulmonary status and, hemodynamic responses in neonates with congestive heart failure
Determining and comparing the effect of continuous injection versus intermittent bolus injection of furosemide on pulmonary condition and hemodynamic responses of infants with heart failure.
Design
Two arm parallel group randomized trial with blinded postoperative care and outcome assessment design of130 patients.
Settings and conduct
Furosemide drug in the continuous administration group will start with an initial dose of 0.1 mg per kilogram of body weight per hour, and the drug dose can be doubled every 2 hours (the maximum dose received is 6 mg per kilogram of body weight per day) in The intermittent bolus administration method, the initial dose of 1 mg per kilogram of body weight will be administered every 12 hours daily. Average pulmonary function indices and hemostatic responses will be recorded every 4 hours and then at the end of 48 hours after the start of treatment.
Participants/Inclusion and exclusion criteria
Inclusion criteria include all infants from birth to 28 days, weight over 1000 grams, symptoms of heart failure and Symptoms of respiratory distress (tachycardia, tachypnea) will be a drop in oxygen saturation and a decrease in urinary output. Babies with an age of more than 28 days, a birth weight of less than 1000 grams, severe electrolyte disorders and the presence of shock symptoms are excluded from the study.
Intervention groups
Neonates with heart failure are randomly divided into two groups, one group is given continuous intravenous furosemide and the next group is prescribed intermittently.
Main outcome variables
Reducing the duration of heart failure treatment, electrolyte disturbances, the time of mechanical ventilation and kidney complications.
General information
Reason for update
Acronym
CHF
IRCT registration information
IRCT registration number:IRCT20210317050737N1
Registration date:2022-11-29, 1401/09/08
Registration timing:prospective
Last update:2022-11-29, 1401/09/08
Update count:0
Registration date
2022-11-29, 1401/09/08
Registrant information
Name
Maryam Ahmadipour
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 34 3247 0346
Email address
m.ahmadipour@kmu.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2023-01-21, 1401/11/01
Expected recruitment end date
2023-06-22, 1402/04/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparison of the effects of continuous versus bolus intermittent Furosemide infusion on the pulmonary status and, hemodynamic responses in neonates with congestive heart failure
Public title
Comparison of intravenous and intermittent furosemide injection on pulmonary status and heart failure of newborns
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
All term newborn boys and girls, diagnosed with heart failure
Exclusion criteria:
Neonate with an age of more than 28 days, a birth weight of less than 1000 grams, severe electrolyte disorders and the presence of shock symptoms are excluded from the study.
Age
From 1 day old to 28 days old
Gender
Both
Phase
2
Groups that have been masked
Investigator
Outcome assessor
Sample size
Target sample size:
130
Randomization (investigator's opinion)
Randomized
Randomization description
Simple randomization is done using a Random number table and Numbered containers in such a way that infants with heart failure with even numbers are placed in the continuous treatment group and with odd numbers in the intermittent treatment group by the resident physician.
Blinding (investigator's opinion)
Double blinded
Blinding description
The person who is responsible for collecting information and evaluating the outcome is blinded to the method of intervention.
Placebo
Not used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethics committee of Kerman University of Medical Sciences
Street address
No. 6, Eest Zohre kermani Ave.Emam jomeh Blvd.
City
Kerman
Province
Kerman
Postal code
7619643781
Approval date
2022-11-13, 1401/08/22
Ethics committee reference number
1401-117
Health conditions studied
1
Description of health condition studied
Heart failure
ICD-10 code
I50
ICD-10 code description
Heart failure
Primary outcomes
1
Description
Heart failure
Timepoint
Pulmonary function indicators and hemodynamic responses of infants will be reported every 4 hours and urinary output every 6 hours and at the end of every 48 hours after treatment with an average score.
Method of measurement
Echocardiography
Secondary outcomes
1
Description
Treatment of heart failure
Timepoint
Pulmonary function indicators and hemodynamic responses of infants will be reported every 4 hours and urinary output every 6 hours and at the end of every 48 hours after treatment with an average score.
Method of measurement
Echocardiography
Intervention groups
1
Description
In the intervention group, continuous administration will start with an initial dose of 0.1 mg per kilogram of body weight per hour, and the drug dose can be doubled every 2 hours, with a maximum dose of 0.4 mg per kilogram of body weight.
Category
Treatment - Drugs
Recruitment centers
1
Recruitment center
Name of recruitment center
Afzali pour hospital
Full name of responsible person
Maryam Ahmadipour
Street address
No. 6, Eest Zohre Kermani Ave., Emam jomeh Blvd.,
City
Kerman
Province
Kerman
Postal code
7619643781
Phone
+98 34 3223 0346
Email
maryam.ahmadipour5@gmail.com
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Kerman University of Medical Sciences
Full name of responsible person
Maryam Ahmadipour
Street address
No. 6, Eest Zohre Kermani Ave., Emam jomeh Blvd.
City
Kerman
Province
Kerman
Postal code
7619643781
Phone
+98 34 3223 0346
Email
maryam.ahmadipour5@gmail.com
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Kerman University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic
Person responsible for general inquiries
Contact
Name of organization / entity
Kerman University of Medical Sciences
Full name of responsible person
Maryam Ahmadipour
Position
Assistant Professor
Latest degree
Subspecialist
Other areas of specialty/work
Pediatrics
Street address
No. 6, Eest Zohreh Kermani Ave., Emam Jomeh Blvd
City
Kerman
Province
Kerman
Postal code
7619647381
Phone
+98 31 3223 0346
Email
maryam.ahmadipour5@gmail.com
Person responsible for scientific inquiries
Contact
Name of organization / entity
Kerman University of Medical Sciences
Full name of responsible person
Maryam Ahmadipour
Position
Assistant Professor
Latest degree
Subspecialist
Other areas of specialty/work
Pediatrics
Street address
No. 6, Eest Zohre Kermani Ave., Emam Jomeh Blvd
City
Kerman
Province
Kerman
Postal code
7619643781
Phone
009834332230346
Email
maryam.ahmadipour5@gmail.com
Person responsible for updating data
Contact
Name of organization / entity
Kerman University of Medical Sciences
Full name of responsible person
Maryam Ahmadipour
Position
Assistant professor
Latest degree
Subspecialist
Other areas of specialty/work
Pediatrics
Street address
No. 6,Eest Zohreh Kermani Ave.,Emam Jomeh Blvd
City
Kerman
Province
Kerman
Postal code
7619643781
Phone
+98 34 3223 0346
Email
maryam.ahmadipour5@gmail.com
Sharing plan
Deidentified Individual Participant Data Set (IPD)
No - There is not a plan to make this available
Justification/reason for indecision/not sharing IPD